Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Regulated (List II)
MEBEVERINE BEKER LP
200MG/Extended-release Microgranules in Capsule/MEBEVERINE CHLORHYDRATE
ManufacturerVerified lab
BEKER
Public retail price
N/ADZD
Reference price (TR): 217.20 DZD
Identification
- Active ingredient (INN)
- MEBEVERINE CHLORHYDRATE
- Internal code
- 10 E 116
- Country of Origin
- Algeria
- Pharmaceutical form
- Extended-release Microgranules in Capsule
- Prescription List
- Regulated (List II)
- Packaging
- b/30
Clinical View
Regulated (List II)
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.
Indications
Not Available
Mechanism of Action
Target Actions Organism U Muscarinic acetylcholine receptor M5 antagonist Humans.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.